Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922047
Status:
UNKNOWN
Last Update Posted:
2021-06-11
First Post:
2021-06-06
Brief Title:
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients TACBIN-01
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Organization Data
Organization:
RenJi Hospital
Class:
OTHER
Study ID:
KY2021-041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RenJi Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| BeiGene | INDUSTRY |
| Huidu Shanghai Medical Sciences Ltd | UNKNOWN |